–
Sionna Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−41.4
FY23:
−50.3
FY24:
−70.6
FY25:
−89.0
(positive)
Change from FY22 to FY25
millions USD
FY22:
−41.3
FY23:
−49.8
FY24:
−69.9
FY25:
−88.3
(positive)
Change from FY22 to FY25
millions USD
FY22:
−40.2
FY23:
−47.3
FY24:
−61.7
FY25:
−75.3
(positive)
Change from FY22 to FY25
millions USD
FY22:
−40.2
FY23:
−47.3
FY24:
−61.7
FY25:
−75.3
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.